1. Home
  2. FUND vs GOSS Comparison

FUND vs GOSS Comparison

Compare FUND & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FUND
  • GOSS
  • Stock Information
  • Founded
  • FUND 1988
  • GOSS 2015
  • Country
  • FUND Canada
  • GOSS United States
  • Employees
  • FUND N/A
  • GOSS N/A
  • Industry
  • FUND Investment Managers
  • GOSS Biotechnology: Pharmaceutical Preparations
  • Sector
  • FUND Finance
  • GOSS Health Care
  • Exchange
  • FUND Nasdaq
  • GOSS Nasdaq
  • Market Cap
  • FUND 236.5M
  • GOSS 237.9M
  • IPO Year
  • FUND N/A
  • GOSS 2019
  • Fundamental
  • Price
  • FUND $7.51
  • GOSS $0.85
  • Analyst Decision
  • FUND
  • GOSS Strong Buy
  • Analyst Count
  • FUND 0
  • GOSS 5
  • Target Price
  • FUND N/A
  • GOSS $9.20
  • AVG Volume (30 Days)
  • FUND 32.5K
  • GOSS 2.0M
  • Earning Date
  • FUND 01-01-0001
  • GOSS 03-04-2025
  • Dividend Yield
  • FUND 6.64%
  • GOSS N/A
  • EPS Growth
  • FUND N/A
  • GOSS N/A
  • EPS
  • FUND 0.93
  • GOSS N/A
  • Revenue
  • FUND N/A
  • GOSS $105,322,000.00
  • Revenue This Year
  • FUND N/A
  • GOSS N/A
  • Revenue Next Year
  • FUND N/A
  • GOSS N/A
  • P/E Ratio
  • FUND $8.33
  • GOSS N/A
  • Revenue Growth
  • FUND N/A
  • GOSS N/A
  • 52 Week Low
  • FUND $6.75
  • GOSS $0.50
  • 52 Week High
  • FUND $8.47
  • GOSS $1.60
  • Technical
  • Relative Strength Index (RSI)
  • FUND 48.96
  • GOSS 45.25
  • Support Level
  • FUND $7.29
  • GOSS $0.81
  • Resistance Level
  • FUND $7.56
  • GOSS $1.18
  • Average True Range (ATR)
  • FUND 0.07
  • GOSS 0.09
  • MACD
  • FUND 0.03
  • GOSS -0.00
  • Stochastic Oscillator
  • FUND 85.71
  • GOSS 12.74

About FUND Sprott Focus Trust Inc.

Sprott Focus Trust Inc is a diversified closed-end investment company. Its primary investment objective is long-term capital growth. To achieve its objective, The Fund may invest its assets in equity securities and in direct obligations of the U.S. Government or its agencies and in the non-convertible preferred stocks & debt securities of domestic and foreign companies. It invests in various sectors, of which Materials, Financials, Energy, Information technology sector account for the majority weightage.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: